As of 2026-03-22, the Relative Valuation of Brooklyn Immunotherapeutics Inc (BTX) is 433.62 USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.38 USD, the upside of Brooklyn Immunotherapeutics Inc based on Relative Valuation is 6696.6%.
The range of the Relative Valuation is 319.75 - 578.08 USD.
| Range | Selected | |
| Trailing P/E multiples | 27.4x - 38.7x | 35.3x |
| Forward P/E multiples | 21.5x - 27.5x | 22.8x |
| Fair Price | 319.75 - 578.08 | 433.62 |
| Upside | 4911.8% - 8960.8% | 6696.6% |
| Date | P/E |
| 2026-03-12 | 0.42 |
| 2026-03-11 | 0.43 |
| 2026-03-10 | 0.43 |
| 2026-03-09 | 0.43 |
| 2026-03-06 | 0.43 |
| 2026-03-05 | 0.44 |
| 2026-03-04 | 0.44 |
| 2026-03-03 | 0.44 |
| 2026-03-02 | 0.45 |
| 2026-02-27 | 0.44 |
| 2026-02-26 | 0.44 |
| 2026-02-25 | 0.45 |
| 2026-02-24 | 0.44 |
| 2026-02-23 | 0.44 |
| 2026-02-20 | 0.45 |
| 2026-02-19 | 0.44 |
| 2026-02-18 | 0.44 |
| 2026-02-17 | 0.44 |
| 2026-02-13 | 0.43 |
| 2026-02-12 | 0.43 |
| 2026-02-11 | 0.44 |
| 2026-02-10 | 0.45 |
| 2026-02-09 | 0.45 |
| 2026-02-06 | 0.44 |
| 2026-02-05 | 0.42 |
| 2026-02-04 | 0.43 |
| 2026-02-03 | 0.43 |
| 2026-02-02 | 0.44 |
| 2026-01-30 | 0.45 |
| 2026-01-29 | 0.46 |
| 2026-01-28 | 0.46 |
| 2026-01-27 | 0.45 |
| 2026-01-26 | 0.45 |
| 2026-01-23 | 0.45 |
| 2026-01-22 | 0.45 |
| 2026-01-21 | 0.45 |
| 2026-01-20 | 0.45 |
| 2026-01-16 | 0.46 |
| 2026-01-15 | 0.46 |
| 2026-01-14 | 0.46 |
| 2026-01-13 | 0.46 |
| 2026-01-12 | 0.45 |
| 2026-01-09 | 0.45 |
| 2026-01-08 | 0.45 |
| 2026-01-07 | 0.46 |
| 2026-01-06 | 0.46 |
| 2026-01-05 | 0.45 |
| 2026-01-02 | 0.45 |
| 2025-12-31 | 0.44 |
| 2025-12-30 | 0.44 |